Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HUBS

Go back to Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata
(NASDAQ: QTTB) Delayed: 11.99 -0.81 (6.33%)
Previous Close $12.80    52 Week High $ 
Open $12.60    52 Week Low $ 
Day High $12.70    P/E N/A 
Day Low $11.50    EPS $ 
Volume 853,811